Fetero has the experience and forward thinking to help you ensure patient safety and access, while maximizing your product’s value and commercial success. Every product, patient and market is unique and so are the programs you need to maximize your therapy’s commercial success.
Post Market Solutions
Post-Marketing Solutions
Health Economics and Patient Outcomes
Delivering commercially relevant and scientifically rigorous evidence to elevate your product’s value proposition and optimize reimbursement potential.
Generating scientific and commercial evidence to elevate product value and reimbursement potential. Fetero’s health economics and outcomes services span the entire product lifecycle to generate scientifically rigorous and commercially relevant evidence, and ensure that the patient voice is captured to elevate the client’s product value proposition and reimbursement potential.
Services through all stages of development and commercialization
Our experts use established methods and innovative tailored solutions to help pharma, biotech and medical device clients generate HEOR evidence, meet specific HTA challenges with early advice and submissions, support market access and bolster arguments for product reimbursement.
- 1-Strategic consulting
Development of global HEOR strategy, including strategic roadmaps and evidence generation for early product planning; Advisory boards to externally validate the strategy; and regulatory support for FDA and EMA activities
- 2-Evidence synthesis
Systematic and targeted literature reviews on efficacy and safety, costs, economic evaluations, clinical outcome assessments, HrQoL utilities
- 3-Outcomes selection
Selection, design, development, and validation of clinical outcome assessments (COAs) and refinement of endpoint selections, preparation of COA dossiers for regulatory submissions; Cognitive debriefing & usability testing (CDUT) and analysis of data for equivalent testing of COAs migrated to electronic platforms
- 4-Economic modelling
De novo development of global economic models for HTA/reimbursement submissions, including survival analysis modelling and local country adaptations
- 5-Patient preference studies and utility measurement
Discrete choice experiments; design & evaluation of patient support and adherence programs; data generation for utility measurement data used in economic modelling and HTA submissions
- 6-HTA submissions and early advice
Formal and informal scientific advice to understand evidence generation plans to support HTA / reimbursement, including briefing book preparation, and scientific advice meeting preparation and support; and development of HTA dossiers
- 7-Value communications
Development of global value dossiers and payer engagement slide decks, objection handlers, and toolkits
Market Access, Pricing and Reimbursement
Delivering strategic market access parties, to define, capture and communicate the value of medical therapies for optimal commercial results and greater patient access.
Our in-house team of experts guides clients through ever-changing market challenges, using innovation to demonstrate the value of their therapies to ensure access.
Our in-house experts provide the market access experience and innovative solutions you need.
-Payer strategists
In-depth knowledge from former payers and payer experts
-Market research and analytics
Analytics that move data to actionable insights
-Pharmacists
Medical experts to drive clinically sound solutions
-Creative and digital experts
Optimise delivery and ensure positive user experience
-Global access strategists
Expertise for global pricing and access strategies
Market Access delivers customised solutions in global markets
–Pricing, contracting, and access potential evaluation
–Prioritisation, segmentation, and targeting
–Policy/HealthTechnology Assessment
–Market research, including advisory boards and rapid panels
–Payer value communication tools
–Market access field and implementation training
–Reimbursement and patient support
–Pull-through programmes
Medical and Value Communications
We combine strategic consulting with innovative, insightful and impactful tactics to communicate your procut’s value to external stakeholders and optimize the impact of your clinical and outcomes data.
We combines strategic consulting with delivery of innovative, insightful and impactful tactics to communicate your product’s value to external stakeholders and optimise the impact of your clinical and outcomes data.
·Strategic consulting
Our experienced medical communications strategists and scientific experts develop and implement customised, strategically aligned communication plans.
From evidence generation planning and platform development, to generation of comprehensive, evidence-based tactical plans, our scientific teams partner with you to ensure optimised dissemination of a product’s clinical and outcomes data across a variety of audiences and venues. We offer consultation on:
- Medical strategies
- Scientific platforms
- Lexicons
- Communication plans
- Publication plans
- SOPs and best practices
·Communication plan implementation
Fetero’s Medical Communications team includes scientific staff with advanced credentials who are responsible for the quality and accuracy of every deliverable. They work alongside an experienced account team to ensure outstanding operational delivery across a breadth of medical communications initiatives, including live meetings, publications, training programs and digital platforms.
We provide preclinical, clinical and HEOR publications including:
- Primary manuscripts
- Posters
- Abstracts
- Dossiers
- Newsletters
- White papers
- Reviews
- Literature analyses
We support Medical Affairs with the tools and solutions to deliver compelling communications:
- Educational materials
- MSL tools
- Training
- Medical information
- Live and virtual events
At Fetero, we are able to improve brand performance by leveraging data and insights, accumulated best practices and deep access to therapeutic expertise. Serving customers of all sizes, our CCO (Contract Commercial Organization) capabilities are the broadest and most robust in the industry delivering flexible, targeted, multi-channel programs designed to produce a higher likelihood of launch success. At the same time, our commercial and market insights along with proprietary data access can improve clinical trial design and accelerate patient recruitment. It’s a powerful platform for the modern biopharmaceutical world.